Idex Health & Science has launched a newly expanded portfolio of fluidic, microfluidic, and optical components and capabilities.
Four transplant centers are participating in an early access program for the company’s blood test for kidney transplant recipients.
The caps are suitable for biobanks and other laboratory facilities requiring long-term sample storage at low temperatures.
A special latching feature enables the valve to remain in open or closed positions over indefinite periods of time without consuming battery power.
The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
In partnership with biopharmaceutical companies, Leica Biosystems and Advanced Cell Diagnostics are collaborating to develop and commercialize fully automated RNAscope-based companion diagnostics.
With the acquisition, Abbott gains leadership in the $5.5 billion point-of-care segment, broadens its diagnostics footprint, and enhances access to fast-growing diagnostics channels.
This month's Product Spotlight features equipment, consumables, and labware from companies such as EKF Diagnostics, Olympus, Platinum Code, and Randox Laboratories.
This month's Product News includes focused gene expression panels, a cystatin C assay, a supply and procedure cart system, and a modular embedding system.
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Named Grail, the business seeks to enable early cancer detection via blood-based screening.
The assay was developed to offer confidence in patient results through standardization to the World Health Organization’s 3rd international standard for human thyroid stimulating hormone testing.
The line of labels is designed to stay secure on curved surfaces, including dishes, flasks, tubes, and vials.
The companies have partnered to develop a comprehensive next-generation sequencing workflow for single-cell analyses.
GenomeDx Biosciences recently presented first validation data supporting the use of its Decipher test to help guide the treatment of men newly diagnosed with prostate cancer.
The unit covers a temperature range of 4°C to 50°C to allow application flexibility.
Acquisition gives PE access to an innovative noninvasive prenatal testing solution under development, expanding the company’s maternal–fetal health portfolio.
The company reports that clinical trials using its MosaiQ transfusion diagnostic instrument and associated assays will begin later this year.
Lab managers and supervisors are given simplified remote access to their test utilization metrics.